GlaxoSmithKline transfers rare disease gene therapy portfolio to Orchard Therapeutics in strategic deal

GlaxoSmithKline (GSK), a leading British pharmaceutical company, has entered into a significant agreement with Orchard Therapeutics, transferring its rare disease gene therapy drugs in exchange ... Read More